Hemab Therapeutics recently announced positive results from a Phase 2 clinical study of their investigational subcutaneous therapy sutacimig. Sutacimig is a laboratory-engineered bispecific antibody being developed as the first-ever…
The National Bleeding Disorders Foundation (NBDF) is delighted to announce that Luke Luckey of Manchester, Michigan, was selected as the recipient of the 2025 Kevin Child Scholarship (KCS). The Child family selected Luke as this year’s KCS award…
(Editors note: January 22, 2026. Following publication of this joint statement from the National Bleeding Disorders Foundation (NBDF) and the World Federation of Hemophilia (WFH), NBDF received an additional letter from Pfizer. The company stated in…
Dr. Grace joined Children's Hospital Boston / Dana Farber Cancer Institute as a Pediatric Resident after receiving both her undergraduate and doctoral degrees from Brown University. She has since gone on to become a fellow in the institution's…
Speakers: Louise M. Baca, MSN, RN; CC Cook CSW, MPH; Halli Benasutti, PhDJoin us as we look into NBDF's research grant process: what we fund, how to apply, and how NBDF can support you through the process. You'll also hear directly…
Federal Updates: House of Representatives Reintroduces HELP Copays Act In early December, Representatives Kean (R-NJ), Barragan (D-CA), Miller-Meeks (R-IA), Auchincloss (D-MA), Fitzpatrick (R-PA), and…